   
New Nonstimulant on the HorizonA major pharmaceutical company announces positive results from testing of an extended-release nonstimulant. Tuesday May 19th - 4:24pm At an American Psychiatric Association meeting on Monday, the pharmaceutical company Shire announced positive results from the most recent round of tests of the extended-release drug, Intuniv. In particular, the company said the drug showed "significant" improvement in "oppositional" symptoms exhibited by some children with ADHD, such as defiant or angry behavior. Shire is now awaiting FDA approval of the medication. Intuniv is an extended release form of guanfacine, a nonstimulant medication used to treat hypertension. Some doctors have used guanfacine off-label to treat ADHD in people who have trouble tolerating stimulants. |
|
